Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

R De Caterina, S Husted, L Wallentin… - Thrombosis and …, 2013 - thieme-connect.com
Oral anticoagulants are a mainstay of cardiovascular therapy, and for over 60 years vitamin
K antagonists (VKAs) were the only available agents for long-term use. VKAs interfere with …

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease …

Coordinating Committee, R De Caterina… - Journal of the American …, 2012 - jacc.org
Until recently, vitamin K antagonists were the only available oral anticoagulants, but with
numerous limitations that prompted the introduction of new oral anticoagulants targeting the …

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial …

D Brieger, J Amerena, JR Attia… - Medical Journal of …, 2018 - Wiley Online Library
Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk …

Authors/Task Force Members… - European heart …, 2009 - academic.oup.com
Thus, the task of writing Guidelines or Expert Consensus Documents covers not only the
integration of the most recent research, but also the creation of educational tools and …

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk …

D Poldermans, JJ Bax, E Boersma… - European Journal of …, 2010 - journals.lww.com
Guidelines for pre-operative cardiac risk assessment and per... : European Journal of
Anaesthesiology | EJA Guidelines for pre-operative cardiac risk assessment and perioperative …

Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants

RLC Adams, RJ Bird - Nephrology, 2009 - Wiley Online Library
Coagulation involves the regulated sequence of proteolytic activation of a series of
zymogens to achieve appropriate and timely haemostasis in an injured vessel, in an …

General mechanisms of coagulation and targets of anticoagulants (Section I)

R De Caterina, S Husted, L Wallentin… - Thrombosis and …, 2013 - thieme-connect.com
Contrary to previous models based on plasma, coagulation processes are currently believed
to be mostly cell surface-based, including three overlapping phases: initiation, when tissue …

Thrombin: a pivotal player in hemostasis and beyond

JB Larsen, AM Hvas - Seminars in Thrombosis and Hemostasis, 2021 - thieme-connect.com
The serine protease thrombin, a naturally derived enzyme, plays a key role in hemostasis by
converting fibrinogen to fibrin and activating coagulation factor XIII whereby the fibrin clot is …

Prediction of warfarin dose: why, when and how?

N Eriksson, M Wadelius - Pharmacogenomics, 2012 - Taylor & Francis
Prediction models are the key to individualized drug therapy. Warfarin is a typical example of
where pharmacogenetics could help the individual patient by modeling the dose, based on …

A tetracationic aggregation induced emission-based probe for efficient and improved detection of Heparin

SP Pandey, P Jha, DN Nadimetla, SV Bhosale… - Sensors and Actuators B …, 2022 - Elsevier
Designing efficient fluorescent probes with Aggregation Induced Emission (AIE) feature,
especially for sensing biologically important analytes, is an intensive area of investigation …